Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020

I Van Walle, K Leitmeyer, E K Broberg on behalf of the European COVID-19 microbiological laboratories group
doi: https://doi.org/10.1101/2020.09.16.20195917

Article usage

Article usage: September 2020 to March 2025

AbstractFullPdf
Sep 202010990667
Oct 20206370649
Nov 20204230315
Dec 20203450166
Jan 20211970155
Feb 20211670121
Mar 2021146499
Apr 2021143583
May 2021103746
Jun 2021125837
Jul 202193470
Aug 2021771141
Sep 202185244
Oct 202180557
Nov 202166239
Dec 2021130441
Jan 202292545
Feb 202277225
Mar 202264114
Apr 202262314
May 202235416
Jun 20223067
Jul 20223258
Aug 2022361111
Sep 2022541615
Oct 202243912
Nov 20223599
Dec 202224712
Jan 202326812
Feb 2023432314
Mar 202345710
Apr 20232868
May 202310812
Jun 2023131111
Jul 20231438
Aug 2023161812
Sep 20231596
Oct 20231727
Nov 202325105
Dec 20231536
Jan 20241256
Feb 20241246
Mar 2024121310
Apr 202413124
May 202418104
Jun 20241925
Jul 20248210
Aug 20241258
Sep 20242449
Oct 2024171011
Nov 20241426
Dec 20241024
Jan 20251314
Feb 202514157
Mar 202526135
Back to top
Posted September 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
I Van Walle, K Leitmeyer, E K Broberg
medRxiv 2020.09.16.20195917; doi: https://doi.org/10.1101/2020.09.16.20195917
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area